SEC 13F Intelligence

Gagnon Advisors, LLC / PCRX

Gagnon Advisors, LLC’s Pacira Biosciences Inc Position

Does Gagnon Advisors, LLC own Pacira Biosciences Inc (PCRX)? Yes — 352.6K shares worth $8M (+5.86% of its 13F portfolio) as of Q1 2026, up from 260.9K shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
352.6K
% of Portfolio
+5.86%
Quarters Held
28
currently held

Position History PCRX

Reported value by quarter
Q2 ’19: $5MQ2 ’19Q3 ’19: $7MQ4 ’19: $9MQ1 ’20: $7MQ2 ’20: $10MQ2 ’20Q3 ’20: $12MQ4 ’20: $12MQ1 ’21: $14MQ2 ’21: $13MQ2 ’21Q3 ’21: $13MQ4 ’21: $15MQ1 ’22: $19MQ2 ’22: $14MQ2 ’22Q3 ’22: $10MQ4 ’22: $7MQ1 ’23: $7MQ2 ’23: $7MQ2 ’23Q3 ’23: $6MQ4 ’23: $5MQ1 ’24: $4MQ2 ’24: $4MQ2 ’24Q3 ’24: $2MQ4 ’24: $3MQ1 ’25: $3MQ2 ’25: $5MQ2 ’25Q3 ’25: $5MQ4 ’25: $7MQ1 ’26: $8Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026352.6K$8M+5.86%
Q4 2025260.9K$7M+4.29%
Q3 2025213.4K$5M+3.40%
Q2 2025213.4K$5M+3.43%
Q1 2025133.4K$3M+2.34%
Q4 2024133.4K$3M+1.61%
Q3 2024133.4K$2M+1.30%
Q2 2024133.4K$4M+2.91%
Q1 2024133.4K$4M+3.38%
Q4 2023133.4K$5M+3.93%
Q3 2023180.3K$6M+4.63%
Q2 2023180.3K$7M+4.84%
Q1 2023180.3K$7M+4.94%
Q4 2022180.3K$7M+4.70%
Q3 2022180.3K$10M+6.21%
Q2 2022235.4K$14M+8.31%
Q1 2022251.1K$19M+8.83%
Q4 2021251.1K$15M+6.00%
Q3 2021240.1K$13M+5.33%
Q2 2021213.2K$13M+4.92%
Q1 2021193.9K$14M+2.87%
Q4 2020193.9K$12M+5.21%
Q3 2020193.9K$12M+7.15%
Q2 2020193.9K$10M+7.32%
Q1 2020193.9K$7M+6.07%
Q4 2019193.9K$9M+4.92%
Q3 2019193.9K$7M+4.58%
Q2 2019107.4K$5M+2.67%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gagnon Advisors, LLC’s full portfolio or all institutional holders of PCRX.